Deepseq
2 known investors
DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.
Founders & leadership
BS
Bernhard SuterinFounder
Investors · 2
Competitors · 2
by search overlapDeepSee5 shared keywordsDeepSee.ai develops technology aimed at supporting knowledge workers and improving business operations. The page provides limited detail beyond a hiring notice.
Deepchecks4 shared keywordsDeepchecks offers an enterprise LLM evaluation platform that unifies testing, observability, and monitoring for AI systems in production. It lets AI teams compare prompt/model/agent versions, set up auto-scoring pipelines, create LLM judges and datasets, and integrate LLM app testing into CI/CD.
Companies competing with Deepseq for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Deepseq do?
- DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.
- Who founded Deepseq?
- Deepseq was founded by Bernhard Suter.
- Who are Deepseq's investors?
- Deepseq's investors include Illumina Ventures, ZAKA VC.